Friday, September 23, 2011 12:55:19 PM
BMRN:
Thanks for posting the note.
Personally I've become more bullish on 701 in part based on anectdotal reports of some patients (who still haven't been put on the 20mg/kg dose) and Genzyme/SNY's continued ERT manufacturing woe's.
On PEG-PAL I think we still need to see the data. The program has some questions in my mind and I don't see it as having the big potential I once thought.
GALNS is still the key...of course Zacks likes to talk about Firdapse (disappointing)
Thanks for posting the note.
Personally I've become more bullish on 701 in part based on anectdotal reports of some patients (who still haven't been put on the 20mg/kg dose) and Genzyme/SNY's continued ERT manufacturing woe's.
On PEG-PAL I think we still need to see the data. The program has some questions in my mind and I don't see it as having the big potential I once thought.
GALNS is still the key...of course Zacks likes to talk about Firdapse (disappointing)
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
